Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
Heng Joo Ng, Lai Heng LeeDepartment of Haematology, Singapore General Hospital, SingaporeAbstract: Inhibitors against replacement clotting factors occur in approximately 30%–40% of patients with hemophilia A and 1.5%–3% of patients with hemophilia B. In this group of pa...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2006-12-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/recombinant-activated-clotting-factor-vii-rfviia-in-the-treatment-of-s-peer-reviewed-article-VHRM |